If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
This cocktail contains: Magnesium Calcium Vitamin B-12 Vitamin C Its beneficial for a variety of conditions, including fatigue, seasonal allergies, depression, and anxiety
CoQ10: This compound is found in the mitochondria, which are the powerhouses of your cells
10.1016/j.jevs.2020.103296 19 GjurasinM.MiklicP.ZupancicB.PerovicD.ZarkovicK.BrcicL.et al (2010)
**Neurological Disorders:** Supportive treatment in certain neurological disorders associated with vitamin B12 deficiency, such as peripheral neuropathy
Loi biotin no tt nht